(Q38406288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Inadequacies of current approaches to prediabetes and diabetes prevention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Michael Bergman

series ordinal

1

1 reference

2 September 2017

publication date

24 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

623-633

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881341%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12020-013-0017-9

5 March 2020

exact match

0 references

cites work

Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

The US health disadvantage relative to other high-income countries: findings from a National Research Council/Institute of Medicine report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

A silent response to the obesity epidemic: decline in US physician weight counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Public health: The toxic truth about sugar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Potential health risks from beverages containing fructose found in sugar or high-fructose corn syrup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

High fructose corn syrup and diabetes prevalence: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Addressing the policy cacophony does not require more evidence: an argument for reframing obesity as caloric overconsumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Food companies' calorie-reduction pledges to improve U.S. diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Physician competencies for prescribing lifestyle medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Achievement of goals in U.S. diabetes care, 1999-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Diabetes's 'health shock' to schooling and earnings: increased dropout rates and lower wages and employment in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

The immediate vs the important

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Biomedical research: paving a pathway to diabetes prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Approach to the patient with prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Analysis & commentary: The US Preventive Services Task Force should consider a broader evidence base in updating its diabetes screening guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Confronting the urgent challenge of diabetes: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Can 'personalized diagnostics' promote earlier intervention for dysglycaemia? Hypothesis ready for testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Inadequacies of absolute threshold levels for diagnosing prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Prevalence, Diagnosis, and Treatment of Impaired Fasting Glucose and Impaired Glucose Tolerance in Nondiabetic U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Global noncommunicable diseases--where worlds meet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Diabetes report card--time for a winning streak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Gaps in residency training should be addressed to better prepare doctors for a twenty-first-century delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Integrating evidence-based clinical and community strategies to improve health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Primary and secondary prevention services in clinical practice. Twenty years' experience in development, implementation, and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Prevention of type 2 diabetes: risk status, clinic, and community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Preparing the 21st century global healthcare workforce

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Translating the Diabetes Prevention Program into an urban medically underserved community: a nonrandomized prospective intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Chronic disease--the need for a new clinical education

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Statins: Is It Really Time to Reassess Benefits and Risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Type 2 Diabetes Prevention in the "Real World": One-year results of the GOAL Implementation Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0017-9

Effective interventions for stemming the growing crisis of diabetes and prediabetes: a national payer's perspective

21 January 2018

1 reference

12 December 2020

Physical function limitations among middle-aged and older adults with prediabetes: one exercise prescription may not fit all.

1 reference

12 December 2020

Outdoor advertising, obesity, and soda consumption: a cross-sectional study

1 reference

12 December 2020

Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches

1 reference

12 December 2020

Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study

1 reference

12 December 2020

Diabetes prevention: global health policy and perspectives from the ground

1 reference

12 December 2020

Screening for type 2 diabetes and dysglycemia

1 reference

12 December 2020

Awareness of prediabetes--United States, 2005-2010.

1 reference

12 December 2020

Analysis & commentary: The Affordable Care Act lays the groundwork for a national diabetes prevention and treatment strategy

1 reference

12 December 2020

The chronic care model and diabetes management in US primary care settings: a systematic review

1 reference

12 December 2020

Translating diabetes research into global communities

1 reference

12 December 2020

Nutritional change is not a simple answer to non-communicable diseases

1 reference

12 December 2020

Analysis & commentary: Global prevention and control of type 2 diabetes will require paradigm shifts in policies within and among countries

1 reference

12 December 2020

1,5-Anhydroglucitol in diabetes mellitus

1 reference

12 December 2020

Integrating clinical care and community health: delivering health

1 reference

12 December 2020

Antihypertensive medications and the risk of incident type 2 diabetes

1 reference

12 December 2020

A call for more effectively integrating behavioral and social science principles into comprehensive diabetes care

1 reference

12 December 2020

One minute for prevention: the power of leveraging to fulfill the promise of health behavior counseling

1 reference

12 December 2020

Behavioral and psychosocial interventions in diabetes: a conceptual review

1 reference

12 December 2020